UBS Group’s Itron ITRI Stock Holding History

UBS Group’s Portfolio ITRI Stock Details ITRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,300	Closed	-$47K	–	7886
2015 Q4	$47K	Buy	+1,300	New	+$45.9K	﹤0.01%	5873

Other funds holding ITRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group's ITRI Position: Q1 2026 in Review

UBS Group increased its Itron (ITRI) stake by 7% in Q1 2026, buying an estimated $3.47M and bringing the position to 555,600 shares worth $49.8M. The position accounts for 0.01% of the portfolio, ranked #1646.

UBS Group first reported a position in ITRI in Q4 2014 and has held it in 46 quarters since. The position peaked at $67.7M in Q1 2025. 431 funds tracked by Wall St. Rank hold ITRI as of Q1 2026.

UBS Group held 555,600 shares of Itron worth $49.8M as of Q1 2026.
UBS Group bought 36,134 Itron shares in Q1 2026, an estimated $3.47M.
Itron made up 0.01% of UBS Group's portfolio in Q1 2026, its #1646 holding.
UBS Group first reported a position in Itron in Q4 2014 and has held it in 46 quarters since.
UBS Group's Itron position peaked at $67.7M in Q1 2025.
431 funds tracked by Wall St. Rank held Itron as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.